Peak match acceleration demands differentiate between elite youth and professional football players

Youth footballers need to be developed to meet the technical, tactical, and physical demands of professional level competition, ensuring that the transition between competition levels is successful. To quantify the physical demands, peak match intensities have been measured across football competition tiers, with team formations and tactical approaches shown to influence these physical demands. To date, no research has directly compared the physical demands of elite youth and professional footballers from a single club utilising common formations and tactical approaches. The current study quantified the total match and peak match running demands of youth and professional footballers from a single Australian A-League club. GPS data were collected across a single season from both a professional (n = 19; total observations = 199; mean ± SD; 26.7 ± 4.0 years) and elite youth (n = 21; total observations = 59; 17.9 ± 1.3 years) team. Total match demands and peak match running demands (1–10 min) were quantified for measures of total distance, high-speed distance [>19.8 km-h-1] and average acceleration. Linear mixed models and effect sizes identified differences between competition levels. No differences existed between competition levels for any total match physical performance metric. Peak total and high-speed distances demands were similar between competitions for all moving average durations. Interestingly, peak average acceleration demands were lower (SMD = 0.63–0.69) in the youth players across all moving average durations. The data suggest that the development of acceleration and repeat effort capacities is crucial in youth players for them to transition into professional competition

Hormonal contraceptive use in football codes in Australia

The recent launch of the new National elite women’s football competitions in Australia has seen a 20–50% increase in grassroots female participation. With the growing participation across grassroots to elite competitions, understanding the health of female athletes should be prioritized. In elite level athletes, hormonal contraceptive (HC) use is common (�50%), however, little is known about the prevalence and reasons for use and disuse of HC in elite female football athletes. As such, the impact of HC use is often not considered when monitoring the health of female footballers. This study involved a subset of data collected as part of a larger questionnaire investigating menstrual cycle function, hormonal contraception use, and the interaction with training load volume and perceived performance in elite female football code athletes. A total of 177 participants completed the questionnaire across three football codes within Australia (rugby league, rugby union/sevens, Australian football). One third (n = 58) of athletes were currently using HC, predominately in the form of an oral contraceptive pill (OC, n = 47). Reasons for use included: to avoid pregnancy (71%); to control/regulate cycle (38%); and to reduce menstrual pain (36%). However, most athletes using an OC (89%) could not identify the type of pill used (e.g., mono-, bi-, or triphasic). The main reason for disuse was due to the negative side effects (n = 23), such as mood swings, weight gain, and depression/anxiety. Comparing HC users and non-users, there were no statistical differences in the number of reported menstrual symptoms, use of medication to relieve menstrual pain, or frequency for needing to adapt training due to their menstrual cycle (p > 0.05). Since most athletes were unaware of the type of OC they used, female football athletes require further education about the different types of HC, and specifically OC, available to them. Similarities in the symptoms experienced, pain management, and training adaptation requirements between groups suggests that HC use may not have the intended outcome for certain athletes. As such, greater awareness of athlete’s personal experiences with the menstrual cycle, how HC may influence their experience, and acknowledgment of non-pharmacological methods to help manage menstrual cycle related symptoms are warranted

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Investigating the Psychophysiological Response to Grade One Muscular Injury in Professional Australian Football Athletes

International Journal of Exercise Science 15(5): 1052-1063, 2022. The purpose of this study was to examine Australian Football athletes’ responses to a grade one muscular injury from a psychophysiological perspective to understand the strength of the association between stress, optimism, and cortisol. Forty-five players listed with one professional Australian Football club volunteered for this study. Inclusion criteria consisted of sustaining a muscular injury during the course of the season with four-weeks predicted recovery time (as diagnosed by club medical staff, n=9). The control group were age, position, and career history matched players from the same sample. Players were also matched for their personality (10-item Big Five Personality Inventory) and fluid intelligence (Raven’s Standard Progressive Matrices). Injured players and matched controls completed perceived stress and optimism measures (paper-based questions) as well as salivary cortisol testing once per week for four weeks. Significant increases in cortisol (p=0.015) and perceived stress (p\u3c0.001) were observed in injured players, along with a reduction in optimism (p\u3c0.001) returning by week 4. A significant positive correlation was found between perceived stress and cortisol (r= 0.426), and significant negative correlations observed between optimism and cortisol r= -0.257 and perceived stress r= -0.391. This study showed that athletes were significantly stressed and less optimistic during the first two-weeks of recovery compared to matched controls. While not statistically significant, large effects observed in cortisol and stress in the week prior to returning to competition in the injured group suggest these results demonstrate that a multi-modality approach can improve understanding of psychophysiological stress following a grade one muscular injury in Australian Football athletes

Neuromuscular Fatigue and Muscle Damage After a Women's Rugby Sevens Tournament

Purpose:To examine relationships between on-field game movement patterns and changes in markers of neuromuscular fatigue and muscle damage during a 2-d women’s rugby sevens tournament.Methods:Female national (mean ± SD n = 12, 22.3 ± 2.5 y, 1.67 ± 0.04 m, 65.8 ± 4.6 kg) and state (n = 10, 24.4 ± 4.3 y, 1.67 ± 0.03 m, 66.1 ± 7.9 kg) representative players completed baseline testing for lower-body neuromuscular function (countermovement-jump [CMJ] test), muscle damage (capillary creatine kinase [CK]), perceived soreness, and perceived recovery. Testing was repeated after games on days 1 and 2 of the tournament. GPS (5-Hz) data were collected throughout the tournament (4−6 games/player).Results:National players were involved in greater on-field movements for total time, distance, high-speed running (&gt;5 m/s), and impacts &gt;10 g (effect size [ES] = 0.55−0.97) and displayed a smaller decrement in performance from day 1 to day 2. Despite this, state players had a much greater 4-fold increase (ΔCK = 737 U/L) in CK compared with the 2-fold increase (ΔCK = 502 U/L) in national players (ES = 0.73). Both groups had similar perceived soreness and recovery while CMJ performance was unchanged. High-speed running and impacts &gt;10 g were largely correlated (r = .66−.91) with ΔCK for both groups.Conclusion:A 2-day women’s rugby sevens tournament elicits substantial muscle damage; however, there was little change in lower-body neuromuscular function. Modest increases in CK can largely be attributed to high-speed running and impacts &gt;10 g that players typically endure.</jats:sec

Comparison of the match running demands of elite and sub-elite women's Australian Football

Objectives: This study aimed to quantify and compare the match running movements of elite (AFLW) and sub-elite (VFLW) women's Australian Football (AF) competitions. Methods: Match running movements (GPS) were recorded during 7 AFLW (n = 91 files) and 13 VFLW (n = 263 files) competition matches. Results: AFLW players covered moderately greater relative high-speed running (HSR, 14.4-18.0 km.h(-1), AFLW 14.9 +/- 5.7 m.min(-1); VFLW 12.2 +/- 3.9 m.min(-1); ES = 0.61, +/- 0.39), very high-speed running (VHSR, 18.0-20.0 km.h(-1), 4.2 +/- 2.0 m.min(-1); 3.2 +/- 1.4 m.min(-1); ES = 0.61, +/- 0.14), and sprint (>20 km.h(-1), 3.3 +/- 2.2 m.min(-1); 2.1 +/- 1.6 m.min(-1); ES = 0.65, +/- 0.16) distances than VFLW players. Small to large differences were apparent within positions between competitions for HSR, VHSR, and sprint distances, most notably in small forwards (ES = 0.78-1.45). VHSR and sprint distances decreased in the fourth quarter when compared with quarters one and two (ES = 0.22-0.33) in the AFLW competition, whereas VFLW match running movements remained consistent across quarters. Conclusions: These differences may reflect the variations in match rules between competitions (fewer on-field players and shorter match time in AFLW), providing greater on-field space per player and interchange frequency. This information can assist in prescribing appropriate training for women's AF competition

Iron monitoring of male and female rugby sevens players over an international season

BACKGROUND: Given the likely influence that high training loads, contact-induced hemolysis and female-specific requirements have on the incidence of iron deficiency, characterizing the direction and magnitude of fluctuations in iron status over an international season is important for managing player health and physical performance in rugby sevens. METHODS: Australian national male (N.=27) and female (N.=23) rugby sevens players undertook blood tests at pre-season, mid-season, and end-season. Hemoglobin (Hb), hematocrit (Hct), ferritin, transferrin and transferrin saturation were quantified. Female athletes also reported oral contraceptive use and a subset (N.=7) provided 7-day food diaries to quantify iron intake. RESULTS: Male players typically had a three-fold higher ferritin concentration than females. Pre-season ferritin concentrations in male (151±66 µg/L) and female (51±24 µg/L) players declined substantially (~20%) by mid-season but recovered by end-season. Over the season 23% of female players were classified as iron deficient (ferritin <30 µg/L) and prescribed supplementation. The greatest incidence of iron deficiency in female players occurred mid-season (30%). Oral contraception and dietary iron intake had an unclear influence on female players’ ferritin concentration, while age was largely positively correlated (r=0.66±~0.33). CONCLUSIONS: Given the relatively low ferritin concentrations evident in female rugby sevens players, and the potential for a further decline midway through a season when physical load may be at its highest, 6-monthly hematological reviews are suggested in combination with dietary management. Annual screening may be beneficial for male players, with further monitoring only when clinically indicated.No Full Tex